← Mechanisms of action
CD47
SINGLE PROTEINHomo sapiens
Preferred name: Leukocyte surface antigen CD47 ChEMBL ↗
Linked proteins
Drugs acting on this target (47)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| daleuton | Activator | experimental | Small molecule | CD47 activator |
| cpo107 | Adcc | experimental | mAb | CD47 adcc |
| gentulizumab | Adcc | experimental | mAb | CD47 adcc |
| ni-1801 | Adcc | experimental | mAb | CD47 |
| 6mw3211 | Antagonist | experimental | mAb | CD47 |
| aur103 | Antagonist | experimental | Small molecule | CD47 |
| aur105 | Antagonist | experimental | Small molecule | cd47 |
| bat7104 | Antagonist | experimental | mAb | CD47 |
| hmpl-a83 | Antagonist | experimental | mAb | CD47 |
| ibi-322 | Antagonist | experimental | mAb | CD47 |
| pf-07257876 | Antagonist | experimental | mAb | CD47 |
| pt217 | Antagonist | experimental | mAb | CD47 |
| pt886 | Antagonist | experimental | mAb | CD47 |
| sb24m | Antagonist | experimental | mAb | CD47 |
| sg2501 | Antagonist | experimental | mAb | CD47 |
| sti-6643 | Antagonist | experimental | mAb | CD47 |
| Imm-0306 | Binding agent | experimental | mAb | CD47 |
| ak117 | Inhibitor | experimental | mAb | CD47 inhibitor |
| ak132 | Inhibitor | experimental | mAb | CD47 inhibitor |
| alx148 | Inhibitor | experimental | mAb | Leukocyte surface antigen CD47 inhibitor |
| ao-176 | Inhibitor | experimental | mAb | CD47 inhibitor |
| bsi-082 | Inhibitor | experimental | Small molecule | CD47 inhibitor |
| cc-90002 | Inhibitor | experimental | mAb | CD47 inhibitor |
| d3l-001 | Inhibitor | experimental | mAb | CD47 inhibitor |
| ds003 | Inhibitor | experimental | Small molecule | CD47 inhibitor |
| fp002 | Inhibitor | experimental | mAb | CD47 inhibitor |
| hcb101 | Inhibitor | experimental | mAb | CD47 inhibitor |
| hu5f9-g4 | Inhibitor | experimental | mAb | CD47 inhibitor |
| hx009 | Inhibitor | experimental | mAb | CD47 inhibitor |
| ibi-322 | Inhibitor | experimental | mAb | CD47 inhibitor |
| ibi188 | Inhibitor | experimental | mAb | CD47 inhibitor |
| imc-002 | Inhibitor | experimental | mAb | CD47 inhibitor |
| imm2520 | Inhibitor | experimental | mAb | CD47 inhibitor |
| isb 1442 | Inhibitor | experimental | mAb | CD47 inhibitor |
| lb101 | Inhibitor | experimental | mAb | CD47 inhibitor |
| magrolimab | Inhibitor | experimental | mAb | Leukocyte surface antigen CD47 inhibitor |
| sg1906 | Inhibitor | experimental | mAb | CD47 inhibitor |
| sgn-cd47m | Inhibitor | experimental | mAb | CD47 inhibitor |
| shr-1603 | Inhibitor | experimental | mAb | CD47 inhibitor |
| srf231 | Inhibitor | experimental | mAb | CD47 inhibitor |
| tg-1801 | Inhibitor | experimental | mAb | CD47 inhibitor |
| tj011133 | Inhibitor | experimental | mAb | CD47 inhibitor |
| tqb2928 | Inhibitor | experimental | Recombinant protein | CD47 inhibitor |
| tti-621 | Inhibitor | experimental | Recombinant protein | CD47 inhibitor |
| tti-622 | Inhibitor | experimental | Recombinant protein | CD47 inhibitor |
| zanolimumab | Inhibitor | experimental | mAb | CD47 inhibitor |
| zl1201 | Inhibitor | experimental | mAb | CD47 inhibitor |